Similar Survival for Patients Undergoing Reduced-Intensity TBI Versus Myeloablative TBI as Conditioning for Allogeneic Transplant in Acute Leukemia

被引：1
|
作者：
Mikell, J. L. [1 ,2 ]
Waller, E. K. [2 ,3 ]
Rangaraju, S. [2 ,3 ]
Switchenko, J. M. [2 ,4 ]
Ali, Z. [2 ,3 ]
Graiser, M. [2 ,3 ]
Hall, W. A. [1 ,2 ]
Langston, A. A. [2 ,3 ]
Esiashvili, N. [1 ,2 ]
Khan, M. K. [1 ,2 ]
机构：
[1] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA
[2] Winship Canc Inst, Atlanta, GA USA
[3] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[4] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2013年 / 87卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2013.06.1478
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S558 / S558
页数：1
相关论文
共 50 条
  • [1] Similar Survival for Patients Undergoing Reduced-Intensity Total Body Irradiation (TBI) Versus Myeloablative TBI as Conditioning for Allogeneic Transplant in Acute Leukemia
    Mikell, John L.
    Waller, Edmund K.
    Switchenko, Jeffrey M.
    Rangaraju, Sravanti
    Ali, Zahir
    Graiser, Michael
    Hall, William A.
    Langston, Amelia A.
    Esiashvili, Natia
    Khoury, H. Jean
    Khan, Mohammad K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (02): : 360 - 369
  • [2] Similar risks for hypothyroidism after allogeneic hematopoietic cell transplantation using TBI-based myeloablative and reduced-intensity conditioning regimens
    A Al-Hazzouri
    Q Cao
    L J Burns
    D J Weisdorf
    N S Majhail
    Bone Marrow Transplantation, 2009, 43 : 949 - 951
  • [3] Similar risks for hypothyroidism after allogeneic hematopoietic cell transplantation using TBI-based myeloablative and reduced-intensity conditioning regimens
    Al-Hazzouri, A.
    Cao, Q.
    Burns, L. J.
    Weisdorf, D. J.
    Majhail, N. S.
    BONE MARROW TRANSPLANTATION, 2009, 43 (12) : 949 - 951
  • [4] Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia
    Dhere, Vishal
    Edelman, Scott
    Waller, Edmund K.
    Langston, Amelia
    Graiser, Michael
    Connolly, Erin C.
    Switchenko, Jeffrey M.
    Esiashvili, Natia
    Khan, Mohammad K.
    LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 837 - 843
  • [5] Reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for patients with myelofibrosis
    Kim, Dong Hyun
    Seo, Jeongmin
    Shin, Dong-Yeop
    Koh, Youngil
    Hong, Junshik
    Kim, Inho
    Yoon, Sung-Soo
    Byun, Ja Min
    BLOOD RESEARCH, 2022, 57 (04) : 264 - 271
  • [6] 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
    R M Sobecks
    R Dean
    L A Rybicki
    J Chan
    K S Theil
    R Macklis
    S Andresen
    M Kalaycio
    B Pohlman
    C Ferraro
    K Cherni
    J Sweetenham
    E Copelan
    B J Bolwell
    Bone Marrow Transplantation, 2008, 42 : 715 - 722
  • [7] 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
    Sobecks, R. M.
    Dean, R.
    Rybicki, L. A.
    Chan, J.
    Theil, K. S.
    Macklis, R.
    Andresen, S.
    Kalaycio, M.
    Pohlman, B.
    Ferraro, C.
    Cherni, K.
    Sweetenham, J.
    Copelan, E.
    Bolwell, B. J.
    BONE MARROW TRANSPLANTATION, 2008, 42 (11) : 715 - 722
  • [8] Myeloablative after reduced-intensity conditioning allogeneic stem cell transplant: toxicity and outcome?
    Cordonnier, C
    Hamladji, R
    Genitsch, A
    Gratwohl, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S361 - S362
  • [9] Reduced Intensity Versus Myeloablative Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
    Fan, Donna
    Sabry, Waleed
    Stakiw, Julie
    MacKay, Rebecca Ellyn
    Bosch, Mark
    Sarker, Sabuj
    Elemary, Mohamed
    BLOOD, 2014, 124 (21)
  • [10] SIMILAR RISKS FOR HYPOTHYROIDISM IN MYELOABLATIVE AND REDUCED-INTENSITY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT SURVIVORS
    Al-Hazzouri, A.
    Cao, Q.
    Burns, L. J.
    Weisdorf, D. J.
    Majbail, N. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 53 - 54
12345